Comparative Evaluation of Tacrolimus 0.1% in Orabase and Triamcinolone Acetonide 0.1% in the Management of Recurrent Apthous Stomatitis (RAS) – A Case Control Study
Background: Recurrent apthous stomatitis (RAS) and recurrent apthous ulcers are common oral ulcers which are associated with a significant amount of pain and reduction in quality of life, where traditional mainstay of treatment is topical steroids. Methodology: A case control study was undertaken on...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Series: | Journal of Pharmacy and Bioallied Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jpbs.jpbs_1498_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850173963297095680 |
|---|---|
| author | Deepthi Chandrika Manukonda Pavan Kumar Yellarthi Suresh Kumar Pakki N V V Satya Bhushan G. V. Radha Venkata Ramani Chintada |
| author_facet | Deepthi Chandrika Manukonda Pavan Kumar Yellarthi Suresh Kumar Pakki N V V Satya Bhushan G. V. Radha Venkata Ramani Chintada |
| author_sort | Deepthi Chandrika Manukonda |
| collection | DOAJ |
| description | Background:
Recurrent apthous stomatitis (RAS) and recurrent apthous ulcers are common oral ulcers which are associated with a significant amount of pain and reduction in quality of life, where traditional mainstay of treatment is topical steroids.
Methodology:
A case control study was undertaken on 90 patients seeking treatment for minor RAS and was divided into three groups. An index ulcer was selected and treated with 0.1% tacrolimus, 0.1% triamcinolone acetonide, and placebo, respectively, for 1 week.
Results:
At the end of day 2, the mean percentage reduction was 44.16%, 79.82% at day 5 and 94.26% at day 7 in the tacrolimus group, which was comparatively higher than the other two groups at day 2, day 5, and day 7. Recurrence was reported in all three groups but was not statistically significant.
Conclusion:
The results of the study suggest that 0.1% tacrolimus is more effective as an immediate mode of treatment than 0.1% triamcinolone acetonide or placebo in the management of recurrent aphthous ulcers. |
| format | Article |
| id | doaj-art-cc8bd185c7bb49ef94bf116a2bc8b4bb |
| institution | OA Journals |
| issn | 0976-4879 0975-7406 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Pharmacy and Bioallied Sciences |
| spelling | doaj-art-cc8bd185c7bb49ef94bf116a2bc8b4bb2025-08-20T02:19:44ZengWolters Kluwer Medknow PublicationsJournal of Pharmacy and Bioallied Sciences0976-48790975-74062024-12-0116Suppl 4S4107S411010.4103/jpbs.jpbs_1498_24Comparative Evaluation of Tacrolimus 0.1% in Orabase and Triamcinolone Acetonide 0.1% in the Management of Recurrent Apthous Stomatitis (RAS) – A Case Control StudyDeepthi Chandrika ManukondaPavan Kumar YellarthiSuresh Kumar PakkiN V V Satya BhushanG. V. RadhaVenkata Ramani ChintadaBackground: Recurrent apthous stomatitis (RAS) and recurrent apthous ulcers are common oral ulcers which are associated with a significant amount of pain and reduction in quality of life, where traditional mainstay of treatment is topical steroids. Methodology: A case control study was undertaken on 90 patients seeking treatment for minor RAS and was divided into three groups. An index ulcer was selected and treated with 0.1% tacrolimus, 0.1% triamcinolone acetonide, and placebo, respectively, for 1 week. Results: At the end of day 2, the mean percentage reduction was 44.16%, 79.82% at day 5 and 94.26% at day 7 in the tacrolimus group, which was comparatively higher than the other two groups at day 2, day 5, and day 7. Recurrence was reported in all three groups but was not statistically significant. Conclusion: The results of the study suggest that 0.1% tacrolimus is more effective as an immediate mode of treatment than 0.1% triamcinolone acetonide or placebo in the management of recurrent aphthous ulcers.https://journals.lww.com/10.4103/jpbs.jpbs_1498_240.1%triamcinolone acetonide0.1%tacrolimusrecurrent apthous stomatitis (ras) |
| spellingShingle | Deepthi Chandrika Manukonda Pavan Kumar Yellarthi Suresh Kumar Pakki N V V Satya Bhushan G. V. Radha Venkata Ramani Chintada Comparative Evaluation of Tacrolimus 0.1% in Orabase and Triamcinolone Acetonide 0.1% in the Management of Recurrent Apthous Stomatitis (RAS) – A Case Control Study Journal of Pharmacy and Bioallied Sciences 0.1% triamcinolone acetonide 0.1% tacrolimus recurrent apthous stomatitis (ras) |
| title | Comparative Evaluation of Tacrolimus 0.1% in Orabase and Triamcinolone Acetonide 0.1% in the Management of Recurrent Apthous Stomatitis (RAS) – A Case Control Study |
| title_full | Comparative Evaluation of Tacrolimus 0.1% in Orabase and Triamcinolone Acetonide 0.1% in the Management of Recurrent Apthous Stomatitis (RAS) – A Case Control Study |
| title_fullStr | Comparative Evaluation of Tacrolimus 0.1% in Orabase and Triamcinolone Acetonide 0.1% in the Management of Recurrent Apthous Stomatitis (RAS) – A Case Control Study |
| title_full_unstemmed | Comparative Evaluation of Tacrolimus 0.1% in Orabase and Triamcinolone Acetonide 0.1% in the Management of Recurrent Apthous Stomatitis (RAS) – A Case Control Study |
| title_short | Comparative Evaluation of Tacrolimus 0.1% in Orabase and Triamcinolone Acetonide 0.1% in the Management of Recurrent Apthous Stomatitis (RAS) – A Case Control Study |
| title_sort | comparative evaluation of tacrolimus 0 1 in orabase and triamcinolone acetonide 0 1 in the management of recurrent apthous stomatitis ras a case control study |
| topic | 0.1% triamcinolone acetonide 0.1% tacrolimus recurrent apthous stomatitis (ras) |
| url | https://journals.lww.com/10.4103/jpbs.jpbs_1498_24 |
| work_keys_str_mv | AT deepthichandrikamanukonda comparativeevaluationoftacrolimus01inorabaseandtriamcinoloneacetonide01inthemanagementofrecurrentapthousstomatitisrasacasecontrolstudy AT pavankumaryellarthi comparativeevaluationoftacrolimus01inorabaseandtriamcinoloneacetonide01inthemanagementofrecurrentapthousstomatitisrasacasecontrolstudy AT sureshkumarpakki comparativeevaluationoftacrolimus01inorabaseandtriamcinoloneacetonide01inthemanagementofrecurrentapthousstomatitisrasacasecontrolstudy AT nvvsatyabhushan comparativeevaluationoftacrolimus01inorabaseandtriamcinoloneacetonide01inthemanagementofrecurrentapthousstomatitisrasacasecontrolstudy AT gvradha comparativeevaluationoftacrolimus01inorabaseandtriamcinoloneacetonide01inthemanagementofrecurrentapthousstomatitisrasacasecontrolstudy AT venkataramanichintada comparativeevaluationoftacrolimus01inorabaseandtriamcinoloneacetonide01inthemanagementofrecurrentapthousstomatitisrasacasecontrolstudy |